DE69107767T2 - Mikroeinkapselung für ein System zur kontrollierten oralen Wirkstoffabgabe. - Google Patents

Mikroeinkapselung für ein System zur kontrollierten oralen Wirkstoffabgabe.

Info

Publication number
DE69107767T2
DE69107767T2 DE69107767T DE69107767T DE69107767T2 DE 69107767 T2 DE69107767 T2 DE 69107767T2 DE 69107767 T DE69107767 T DE 69107767T DE 69107767 T DE69107767 T DE 69107767T DE 69107767 T2 DE69107767 T2 DE 69107767T2
Authority
DE
Germany
Prior art keywords
microencapsulation
delivery system
drug delivery
oral drug
controlled oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69107767T
Other languages
English (en)
Other versions
DE69107767D1 (de
Inventor
Haibang Lee
Soonhong Yuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Research Institute of Chemical Technology KRICT
Original Assignee
Korea Research Institute of Chemical Technology KRICT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Research Institute of Chemical Technology KRICT filed Critical Korea Research Institute of Chemical Technology KRICT
Publication of DE69107767D1 publication Critical patent/DE69107767D1/de
Application granted granted Critical
Publication of DE69107767T2 publication Critical patent/DE69107767T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
DE69107767T 1990-10-11 1991-10-10 Mikroeinkapselung für ein System zur kontrollierten oralen Wirkstoffabgabe. Expired - Fee Related DE69107767T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR900016120 1990-10-11
KR1019910002092A KR930006431B1 (ko) 1990-10-11 1991-02-07 약물의 미세캡슐화 방법

Publications (2)

Publication Number Publication Date
DE69107767D1 DE69107767D1 (de) 1995-04-06
DE69107767T2 true DE69107767T2 (de) 1995-07-13

Family

ID=26628361

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69107767T Expired - Fee Related DE69107767T2 (de) 1990-10-11 1991-10-10 Mikroeinkapselung für ein System zur kontrollierten oralen Wirkstoffabgabe.

Country Status (5)

Country Link
US (2) US5362424A (de)
EP (1) EP0480729B1 (de)
JP (1) JP2523069B2 (de)
KR (1) KR930006431B1 (de)
DE (1) DE69107767T2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102019209475A1 (de) * 2019-06-28 2020-12-31 Beiersdorf Ag Calciumalginatpartikel

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5529914A (en) 1990-10-15 1996-06-25 The Board Of Regents The Univeristy Of Texas System Gels for encapsulation of biological materials
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
FR2694895B1 (fr) * 1992-08-20 1994-11-10 Coletica Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification.
FR2694894B1 (fr) * 1992-08-20 1994-11-10 Coletica Utilisation d'une réaction de transacylation entre un polysaccharide estérifié et une substance polyaminée ou polyhydroxylée pour la fabrication de microparticules, procédé et composition.
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5770609A (en) 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) * 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
ES2070076B1 (es) * 1993-04-20 1996-04-16 Cusi Lab Metodo para aumentar la estabilidad de las nanocapsulas durante su almacenamiento.
WO1996040098A2 (en) 1995-06-07 1996-12-19 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
CA2162586C (en) * 1993-05-13 2006-01-03 David J. Grainger Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
ES2078190B1 (es) * 1994-05-20 1996-08-01 Cusi Lab Procedimiento para el recubrimiento de goticulas o particulas de tamaño nanometrico.
US5776490A (en) * 1996-01-26 1998-07-07 The Center For Innovative Technology Complex protein-walled microcapsules containing lipid-walled microcapsules and method for producing same
US5941256A (en) * 1996-12-24 1999-08-24 Gillette Canada Inc. Dental hygiene article
BR9808109A (pt) 1997-03-31 2000-03-08 Neorx Corp Inibidor terapêutico de células vasculares da musculatura lisa
US5937874A (en) * 1997-06-03 1999-08-17 Gillette Canada Inc. Dental floss having two components which react to form an active agent
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
DE19801811B4 (de) * 1998-01-19 2004-12-23 Stada Arzneimittel Ag Pharmazeutische Zubereitung zur oralen Verabreichung
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
ATE321538T1 (de) * 1998-08-12 2006-04-15 Altana Pharma Ag Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
JP3672008B2 (ja) * 1999-01-20 2005-07-13 シオノギクオリカプス株式会社 硬質カプセル及びその製造方法
KR100541753B1 (ko) * 1999-07-27 2006-01-10 가부시키가이샤 시세이도 마이크로캡슐 및 그 제조방법
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
EP1116515A3 (de) * 2000-01-11 2002-08-21 Givaudan SA Eingekapselte Flüssigkeit
AU7247000A (en) * 2000-01-11 2001-07-19 Givaudan Sa Composite materials
JP2004515453A (ja) * 2000-05-05 2004-05-27 ウィスコンシン・アルムナイ・リサーチ・ファウンデーション 癌を化学療法および放射線療法に付する間に細胞を保護するための組成物および方法
PL365047A1 (en) * 2000-09-20 2004-12-27 Nycomed Pharma As Preparation of vitamin emulsions and concentrates thereof
US6552004B1 (en) * 2000-10-30 2003-04-22 Universite De Montreal Delivery system for entrapping charged macromolecules and a method for preparing same
US6777000B2 (en) 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US20050163846A1 (en) * 2001-11-21 2005-07-28 Eisai Co., Ltd. Preparation composition containing acid-unstable physiologically active compound, and process for producing same
US20030139582A1 (en) * 2002-01-17 2003-07-24 Wang Kai Hua Composition containing biologically active polypeptides suitable for the oral administration
US20030152484A1 (en) * 2002-02-08 2003-08-14 Heilman David L. Means and method of preserving legal rights by obtaining independent DUI test
NO20021592D0 (no) * 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
FR2843301B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
FR2843302B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
FR2843965A1 (fr) * 2002-08-28 2004-03-05 Rhodia Chimie Sa Particules sous forme de poudre et dispersions a base d'alginate modifie, et leurs procedes de preparation
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
NZ539900A (en) * 2002-11-07 2008-03-28 Advanced Bionutrition Corp Nutraceuticals and method of feeding aquatic animals
MXPA05008033A (es) * 2003-01-28 2006-04-28 Collegium Pharmaceutical Inc Composiciones de milnacipran en forma de multiparticulas para administracion oral.
JP2004290745A (ja) * 2003-03-25 2004-10-21 Ajinomoto Co Inc マイクロカプセルの製造法
ES2228243B1 (es) * 2003-03-28 2006-04-01 Universidad De Alcala Microgranulos reticulados biodegradables con un aceite farmaceutico para dirigir farmacos al colon.
US20050084519A1 (en) * 2003-10-17 2005-04-21 Japan Pet Drugs Co., Ltd. Feed for fish and shellfish, additive therefor, and method for producing additive
CA2557107C (en) * 2004-02-23 2009-04-07 Eyesense Ag Process for production of ionically crosslinked polysaccharide microspheres
NZ549838A (en) * 2004-03-26 2010-04-30 Eisai R&D Man Co Ltd Coated controlled-release preparation containing a gastric acid secretion inhibitor
TWI235834B (en) 2004-06-16 2005-07-11 Star Techn Inc Apparatus for probing multi-dies
AU2005271522B2 (en) * 2004-08-04 2011-02-10 Alza Corporation Sustained drug release composition demonstrating an ascending zero order release pattern, methods of manufacturing such a composition
CA2615939A1 (en) * 2005-08-02 2007-02-08 Miv Therapeutics Inc. Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same
JPWO2007037259A1 (ja) * 2005-09-29 2009-04-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 生体内での崩壊性を向上させたパルス製剤
ATE446087T1 (de) 2006-01-23 2009-11-15 Yissum Res Dev Co Mikrokügelchen mit nanokapseln, die ein lipophiles arzneimittel enthalten
EP1991196B1 (de) 2006-03-03 2016-10-12 Fmc Corporation Verfahren und Vorrichtung zur Herstellung von Kapseln.
JP2009538901A (ja) * 2006-06-01 2009-11-12 デクセル ファーマ テクノロジーズ エルティーディー． 複式ユニット製薬的製剤
KR100809920B1 (ko) * 2006-09-22 2008-03-06 다윈이십일주식회사 장기 안정성이 우수한 인삼성분 미세캡슐의 제조방법
US20100105738A1 (en) * 2006-10-06 2010-04-29 Mitsuru Mizuno Extended release formulations of a proton pump inhibitor
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
US20090130160A1 (en) * 2007-11-21 2009-05-21 Fiber Innovation Technology, Inc. Fiber for wound dressing
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
KR101760534B1 (ko) * 2009-09-10 2017-07-21 에프엠씨 코포레이션 이음매 없는 알기네이트 캡슐
WO2013119215A1 (en) 2012-02-08 2013-08-15 Empire Technology Development Llc Coating a substance with graphene
US9724304B2 (en) 2012-06-14 2017-08-08 Temple University—Of the Commonwealth System of Higher Education Nanospheres for therapeutic agent delivery
JP6659075B2 (ja) * 2014-12-26 2020-03-04 ポーラ化成工業株式会社 カプセル体及びその製造方法
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
KR102272566B1 (ko) * 2019-01-18 2021-07-05 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
CN114652697B (zh) * 2022-04-20 2023-10-13 仲恺农业工程学院 一种天然多糖高分子螯合锌微胶囊及其制备方法与应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2766478A (en) * 1951-10-15 1956-10-16 Gasoline Res Ind And Commercia Encapsulating method and apparatus
USRE24899E (en) * 1953-06-30 1960-11-29 Oil-containrab
US3201353A (en) * 1960-06-14 1965-08-17 American Agricultural Chem Co Micro-inclusions and method of making same
DE1467864A1 (de) * 1964-10-03 1969-01-16 Akad Wissenschaften Ddr Verfahren zur Herstellung von kugelartigen Formkoerpern aus wirkstoffhaltigen waessrigen Emulsionen,Suspensionen oder Loesungen
US3396117A (en) * 1965-09-07 1968-08-06 Amp Inc Encapsulation technique
US3576758A (en) * 1966-10-17 1971-04-27 Ncr Co Treatment of polypeptide-containing hydrophilic polymeric capsule wall material with uranium and vanadium compounds
US3594327A (en) * 1969-03-28 1971-07-20 Ncr Co Process for making minute capsules and capsule product
US3819838A (en) * 1970-08-04 1974-06-25 Bush Boake Allen Ltd Encapsulated flavoring composition
US3749799A (en) * 1972-02-04 1973-07-31 Hoffmann La Roche Stable dry vitamin a preparations
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
JPS5176413A (ja) * 1974-12-25 1976-07-02 Toyo Jozo Kk Hifukuzainoseizoho
JPS52125615A (en) * 1976-04-09 1977-10-21 Kyowa Hakko Kogyo Co Ltd Method of making powdered products
US4389419A (en) * 1980-11-10 1983-06-21 Damon Corporation Vitamin encapsulation
US4501726A (en) * 1981-11-12 1985-02-26 Schroeder Ulf Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4749620A (en) * 1984-02-15 1988-06-07 Massachusetts Institute Of Technology Encapsulated active material system
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3509333A1 (de) * 1985-03-15 1986-09-18 Hoechst Ag, 6230 Frankfurt Substituierte benzimidazolderivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
US4908233A (en) * 1985-05-08 1990-03-13 Lion Corporation Production of microcapsules by simple coacervation
ATE106242T1 (de) * 1986-08-28 1994-06-15 Enzacor Pty Ltd Mikrogranuläre zubereitung zur verabreichung biologisch aktiver stoffe in den eingeweideregionen von tieren.
FR2608456B1 (fr) * 1986-12-18 1993-06-18 Mero Rousselot Satia Microcapsules a base de gelatine et de polysaccharides et leur procede d'obtention
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
IL88961A (en) * 1988-01-29 1992-07-15 Basf Ag Stable mixtures containing oxidation-sensitive compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102019209475A1 (de) * 2019-06-28 2020-12-31 Beiersdorf Ag Calciumalginatpartikel

Also Published As

Publication number Publication date
EP0480729A1 (de) 1992-04-15
KR920007622A (ko) 1992-05-27
DE69107767D1 (de) 1995-04-06
KR930006431B1 (ko) 1993-07-16
US5362424A (en) 1994-11-08
JPH07145045A (ja) 1995-06-06
EP0480729B1 (de) 1995-03-01
US5508041A (en) 1996-04-16
JP2523069B2 (ja) 1996-08-07

Similar Documents

Publication Publication Date Title
DE69107767D1 (de) Mikroeinkapselung für ein System zur kontrollierten oralen Wirkstoffabgabe.
NO890283L (no) Legemiddel-avgivelsessystem for forbedret opptak.
DE3787829T2 (de) System für die Periodontaltasche zur kontrollierten Drogenfreisetzung.
DE3771272D1 (de) Pulsierendes arzneistoffabgabesystem.
DE69133445D1 (de) Arzneistoffabgabesystem
DE69501780D1 (de) Schnellkupplung für ein medikamenteninfusionssystem
DE68908456T2 (de) Matrix zur Wirkstoffabgabe.
DE3879895T2 (de) Luftdetektor fuer ein medikamenteninfusionssystem.
DE69020832D1 (de) Mit Ultraschall arbeitender Luftmengendetektor für ein Medikamenten-Infusionssystem.
NO973630D0 (no) System for regulert avgivelse av medikament
DE69302933T2 (de) Arzneimittelabgabesystem
DE3751314T3 (de) Ventil für ein medizinisches Infusionssystem.
DE69014513D1 (de) System des Typs "einmal täglich" zur gepulsten Minocyclinabgabe.
DE3750619D1 (de) System zur Abgabe von Arzneistoffen.
DE68916196T2 (de) Durch den Patienten kontrollierte Analgesie-Sicherheitsbefestigung für ein Medikamenteninfusionssystem.
DE3882670T2 (de) Optisches Kassettenerkennungsgerät für ein Medikamenteninfusionssystem.
DE3886965D1 (de) Zubereitungen zur gesteuerten Wirkstofffreisetzung.
NO882897D0 (no) Avleveringssystem for legemidler.
DK528988D0 (da) Laegemiddelafgivelsessystem
DE69012107D1 (de) Robotersystem für medizinabgabe.
NO903521D0 (no) Aromautleveringssystem for tyggegummi.
DE3850128D1 (de) Steuerungssystem zur Verbindung zwischen Einheiten.
DE69534973D1 (de) Trägerpfosten für ein zahnimplantatsystem
DE3784347T3 (de) Reinigungssystem für ein blutleitungsnetz.
DE69427251D1 (de) Verabreichungssystem für Arzneistoffe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee